Sarah E Deery1, Courtenay M Holscher2, Besma Nejim3, Sara L Zettervall4, Nathan J Aranson5, Devin S Zarkowsky6, Christopher J Abularrage2, Caitlin W Hicks7. 1. Division of Vascular Surgery and Endovascular Therapy, Johns Hopkins University School of Medicine, Baltimore, Md; Division of Vascular and Endovascular Therapy, Maine Medical Center, Portland, Me. 2. Division of Vascular Surgery and Endovascular Therapy, Johns Hopkins University School of Medicine, Baltimore, Md. 3. Division of Vascular Surgery, Penn State Health Milton S. Hershey Medical Center, Hershey, Pa. 4. Division of Vascular Surgery, University of Washington School of Medicine, Seattle, Wash. 5. Division of Vascular and Endovascular Therapy, Maine Medical Center, Portland, Me. 6. Division of Vascular Surgery and Endovascular Therapy, University of Colorado School of Medicine, Aurora, Colo. 7. Division of Vascular Surgery and Endovascular Therapy, Johns Hopkins University School of Medicine, Baltimore, Md. Electronic address: chicks11@jhmi.edu.
Abstract
OBJECTIVE: In randomized controlled trials and retrospective series, women have higher rates of periprocedural stroke and death following carotid endarterectomy and transfemoral carotid artery stenting compared with men. We sought to compare outcomes by sex following transcarotid artery revascularization (TCAR) among patients in the Vascular Quality Initiative (VQI). METHODS: We reviewed all patients in the VQI who underwent TCAR from 2017 to 2020. We stratified the analysis by symptom status. The primary outcome was in-hospital stroke/death, and secondary outcomes were in-hospital stroke and death and 1-year stroke/death, stroke, and death. We used multivariable logistic and Cox regression models to assess the association of sex with in-hospital and 1-year outcomes after adjusting for preoperative and intraoperative characteristics. RESULTS: We identified 15,851 patients who underwent TCAR, of whom 7391 (47%) were symptomatic (2708 or 37% female) and 8460 (53%) were asymptomatic (3097 or 37% female). Women were less frequently considered anatomic high risk than men in both groups (symptomatic: 43% vs 46%; P = .004; asymptomatic: 44% vs 48%; P = .004). Among symptomatic patients, women more often had severe ≥70% stenosis (89% vs 87%; P = .02). There were no differences in in-hospital death, stroke, or stroke/death for women vs men following TCAR among symptomatic or asymptomatic patients (all P > .05). After adjusting for baseline differences between groups, female sex was not associated with in-hospital stroke/death in either symptomatic (odds ratio, 1.05; 95% confidence interval, 0.72-1.56) or asymptomatic (odds ratio, 0.93; 95% confidence interval, 0.53-1.63) patients undergoing TCAR. There were also no differences in 1-year stroke, death, or stroke/death risk for women compared with men with and without symptoms on unadjusted or adjusted analyses (P > .05). CONCLUSIONS: We found no sex differences in in-hospital or 1-year stroke/death following TCAR, regardless of symptom status. TCAR appears to be as safe of a surgical procedure for women as for men in patients with both symptomatic and asymptomatic carotid artery disease.
OBJECTIVE: In randomized controlled trials and retrospective series, women have higher rates of periprocedural stroke and death following carotid endarterectomy and transfemoral carotid artery stenting compared with men. We sought to compare outcomes by sex following transcarotid artery revascularization (TCAR) among patients in the Vascular Quality Initiative (VQI). METHODS: We reviewed all patients in the VQI who underwent TCAR from 2017 to 2020. We stratified the analysis by symptom status. The primary outcome was in-hospital stroke/death, and secondary outcomes were in-hospital stroke and death and 1-year stroke/death, stroke, and death. We used multivariable logistic and Cox regression models to assess the association of sex with in-hospital and 1-year outcomes after adjusting for preoperative and intraoperative characteristics. RESULTS: We identified 15,851 patients who underwent TCAR, of whom 7391 (47%) were symptomatic (2708 or 37% female) and 8460 (53%) were asymptomatic (3097 or 37% female). Women were less frequently considered anatomic high risk than men in both groups (symptomatic: 43% vs 46%; P = .004; asymptomatic: 44% vs 48%; P = .004). Among symptomatic patients, women more often had severe ≥70% stenosis (89% vs 87%; P = .02). There were no differences in in-hospital death, stroke, or stroke/death for women vs men following TCAR among symptomatic or asymptomatic patients (all P > .05). After adjusting for baseline differences between groups, female sex was not associated with in-hospital stroke/death in either symptomatic (odds ratio, 1.05; 95% confidence interval, 0.72-1.56) or asymptomatic (odds ratio, 0.93; 95% confidence interval, 0.53-1.63) patients undergoing TCAR. There were also no differences in 1-year stroke, death, or stroke/death risk for women compared with men with and without symptoms on unadjusted or adjusted analyses (P > .05). CONCLUSIONS: We found no sex differences in in-hospital or 1-year stroke/death following TCAR, regardless of symptom status. TCAR appears to be as safe of a surgical procedure for women as for men in patients with both symptomatic and asymptomatic carotid artery disease.
Authors: Thomas G Brott; Robert W Hobson; George Howard; Gary S Roubin; Wayne M Clark; William Brooks; Ariane Mackey; Michael D Hill; Pierre P Leimgruber; Alice J Sheffet; Virginia J Howard; Wesley S Moore; Jenifer H Voeks; L Nelson Hopkins; Donald E Cutlip; David J Cohen; Jeffrey J Popma; Robert D Ferguson; Stanley N Cohen; Joseph L Blackshear; Frank L Silver; J P Mohr; Brajesh K Lal; James F Meschia Journal: N Engl J Med Date: 2010-05-26 Impact factor: 91.245
Authors: Virginia J Howard; Helmi L Lutsep; Ariane Mackey; Bart M Demaerschalk; Albert D Sam; Nicole R Gonzales; Alice J Sheffet; Jenifer H Voeks; James F Meschia; Thomas G Brott Journal: Lancet Neurol Date: 2011-05-05 Impact factor: 44.182
Authors: T Bisdas; N Egorova; A J Moskowitz; E A Sosunov; M L Marin; P L Faries; A G Vouyouka Journal: Eur J Vasc Endovasc Surg Date: 2012-07-21 Impact factor: 7.069
Authors: Vincent J Noori; Nathan J Aranson; Mahmoud Malas; Marc Schermerhorn; David O'Connor; Richard J Powell; Jens Eldrup-Jorgensen; Brian W Nolan Journal: J Vasc Surg Date: 2020-07-21 Impact factor: 4.268
Authors: Hideki Ota; Mathew J Reeves; David C Zhu; Arshad Majid; Alonso Collar; Chun Yuan; J Kevin DeMarco Journal: Stroke Date: 2010-07-08 Impact factor: 7.914
Authors: Constantinos T Spyris; Ageliki G Vouyouka; Rami O Tadros; Christine Chung; Michael L Marin; Peter L Faries Journal: Ann Vasc Surg Date: 2012-01 Impact factor: 1.466
Authors: Matthew L Flaherty; Brett Kissela; Jane C Khoury; Kathleen Alwell; Charles J Moomaw; Daniel Woo; Pooja Khatri; Simona Ferioli; Opeolu Adeoye; Joseph P Broderick; Dawn Kleindorfer Journal: Neuroepidemiology Date: 2012-10-11 Impact factor: 3.282